SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-032289
Filing Date
2024-03-15
Accepted
2024-03-15 17:03:05
Documents
101
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K mirm-20231231.htm   iXBRL 10-K 3536158
2 EX-4.3 mirm-ex4_3.htm EX-4.3 18553
3 EX-10.4 mirm-ex10_4.htm EX-10.4 231429
4 EX-10.17 mirm-ex10_17.htm EX-10.17 620435
5 EX-10.19 mirm-ex10_19.htm EX-10.19 18425
6 EX-10.16A mirm-ex10_16a.htm EX-10.16A 54533
7 EX-23.1 mirm-ex23_1.htm EX-23.1 7253
8 EX-31.1 mirm-ex31_1.htm EX-31.1 15584
9 EX-31.2 mirm-ex31_2.htm EX-31.2 14533
10 EX-32.1 mirm-ex32_1.htm EX-32.1 7791
11 EX-32.2 mirm-ex32_2.htm EX-32.2 7785
12 EX-97.1 mirm-ex97_1.htm EX-97.1 51252
13 GRAPHIC img69780980_0.jpg GRAPHIC 61298
  Complete submission text file 0000950170-24-032289.txt   15921226

Data Files

Seq Description Document Type Size
14 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT mirm-20231231.xsd EX-101.SCH 2011631
103 EXTRACTED XBRL INSTANCE DOCUMENT mirm-20231231_htm.xml XML 2761800
Mailing Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404
Business Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Filer) CIK: 0001759425 (see all company filings)

IRS No.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38981 | Film No.: 24755770
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)